Search

Your search keyword '"Stuschke, M"' showing total 1,123 results

Search Constraints

Start Over You searched for: Author "Stuschke, M" Remove constraint Author: "Stuschke, M"
1,123 results on '"Stuschke, M"'

Search Results

11. Combined radiotherapy and concurrent tumor treating fields (TTFields) for glioblastoma: Dosimetric consequences on non-coplanar IMRT as initial results from a phase I trial

13. MO-0952 A multicentric retrospective analysis of the potential synergy between radiotherapy and CAR T-cells

14. First Clinical Experience with Gallium-68-OPS-202 PET for Imaging SCLC

16. DNA-Methylome–Based Tumor Hypoxia Classifier Identifies HPV-Negative Head and Neck Cancer Patients at Risk for Locoregional Recurrence after Primary Radiochemotherapy

22. EP04.02-007 First Comprehensive Lung Cancer Long-Term Survivorship Program- Competing Risks

23. Prognostic factors after pneumonectomy in lung cancer

25. EP04.02-005 First Comprehensive Lung Cancer Long-Term Survivorship Program - Late Toxicities and Overall Survival

26. MA06.08 Long-term Survival and Competing Risks of Death in the ESPATUE Randomized Phase-III Trial in Stage III NSCLC

27. EP04.01-016 First Comprehensive Lung Cancer Long-Term Survivorship Analysis - Late Toxicities and Overall Survival

28. EP05.01-030 CRISP: First Real-World Evidence of NSCLC Stage I, II and III in Germany - AIO-TRK-0315

29. P17.04.B Combination of Trofosfamide and Etoposide in Recurrent Glioma

30. 963P Clinical research platform Into molecular testing, treatment and outcome of non-Small cell lung carcinoma Patients (CRISP): Real-world evidence of NSCLC patients treated with radiochemotherapy in Germany – AIO-TRK-0315

31. OS06.5.A Investigating safety and efficacy of TTFields prior and concomitant to radiotherapy in newly diagnosed glioblastoma - the PriCoTTF phase I/II trial

33. Clinical Research platform Into molecular testing, treatment and outcome of non-Small cell lung carcinoma Patients (CRISP): Real-World Evidence of NSCLC Stage I, II and III in Germany – AIO-TRK-0315

34. 671P Postoperative chemoradiation in combination with cetuximab followed by 6-months cetuximab maintenance in squamous cell carcinoma of the head and neck with high risk of locoregional recurrence

35. P11.15.B First multicentric real-life experience with the combination of lomustine and temozolomide in newly diagnosedMGMT promoter methylatedIDH wildtype glioblastoma

45. Schilddrüsenkarzinom

50. Uveamelanom-Patienten in NRW: die Essener Perspektive

Catalog

Books, media, physical & digital resources